Evidence map›Paper›PMID 40997082›Full record

ArticleAmerican journal of respiratory cell and molecular biology2026

The transcriptional landscape of developing human trisomy 21 lungs.

Soumyaroop Bhattacharya, Andrew Frauenpreis, Caroline Cherry, Gail Deutsch, Ian A Glass, Thomas J Mariani, Denise Al Alam, Soula Danopoulos

Abstract read
In one paragraph

Article in American journal of respiratory cell and molecular biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Soumyaroop BhattacharyaCenter for Children's Health Research, University of Rochester Medical Center, Rochester, NY, United States.ORCID 0000-0003-1140-7845
Andrew FrauenpreisLundquist Institute for Biomedical Innovation, Harbor-UCLA Medical Center, Torrance, CA, United States.
Caroline CherryLundquist Institute for Biomedical Innovation, Harbor-UCLA Medical Center, Torrance, CA, United States.
Gail DeutschDepartment of Laboratory Medicine and Pathology, University of Washington School of Medicine and Seattle Children's Research Institute, Seattle, WA, United States.
Ian A GlassDepartment of Pediatrics, University of Washington School of Medicine, Seattle, WA, United States.
Thomas J MarianiCenter for Children's Health Research, University of Rochester Medical Center, Rochester, NY, United States.
Denise Al AlamLundquist Institute for Biomedical Innovation, Harbor-UCLA Medical Center, Torrance, CA, United States.
Soula DanopoulosLundquist Institute for Biomedical Innovation, Harbor-UCLA Medical Center, Torrance, CA, United States.

Funding

LABORATORY OF DEVELOPMENTAL BIOLOGYR24HD000836 · NICHD · UNIVERSITY OF WASHINGTON · PI Ian Amos Glass · 1995 to 2026
$16.9M
Type I IFN signaling during lung development in Down Syndrome-Multiome sequencing of human fetal and pediatric trisomy 21 lungsR01HL155104 · NHLBI · LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER · PI DANOPOULOS, SOULA ATHANASIA · 2021 to 2025
$3.3M
Mechanisms controlling early human lung developmentR01HL141856 · NHLBI · LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER · PI AL-ALAM, DENISE · 2018 to 2022
$2.5M
Type I interferon regulates angiogenesis in Down Syndrome SupplementR21HL165411 · NHLBI · LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER · PI AL-ALAM, DENISE, DANOPOULOS, SOULA ATHANASIA · 2022 to 2023
$507k
Eunice Kennedy Shriver National Institute of Child Health and Human Development R24HD000836NHLBINHLBI NIH HHS R01 HL141856NHLBI NIH HHS R01HL141856NHLBI NIH HHS R01 HL155104NHLBI NIH HHS R21 HL165411NHLBI NIH HHS R21HL165411NICHD NIH HHS R24 HD000836NIH HHS R01HL155104ODCDC CDC HHS
6 · The paper itself

Abstract

rationaleTrisomy 21 (T21), resulting in Down syndrome (DS), is the most prevalent chromosomal abnormality worldwide. While pulmonary disease is a major cause of morbidity and mortality in DS, the ontogeny of pulmonary complications remains poorly understood. We recently demonstrated that T21 lung anomalies, including airway branching and vascular lymphatic -abnormalities, are initiated in utero. Here, we aimed to describe molecular changes at the single-cell level in prenatal T21 lungs.

methodsSingle-cell RNA sequencing was used to generate transcriptomic profiles of individual human lung cells in tissue obtained from T21 (n = 5) and non-T21 (n = 4) prenatal lungs. Clustering of cells, marker identification, uniform manifold approximation and projection representation, and differential expression analysis were performed in Seurat. Cell type annotation and pathway analysis were annotated using ToppFun and a human fetal lung cell atlas. Spatial differences in cellular phenotypes were validated using immunofluorescence staining and fluorescent in situ hybridization.

resultsOur results detail changes in gene expression at the time of initiation of histopathological abnormalities in T21 prenatal lungs. Notably, we identify precocious differentiation of epithelial cells, widespread induction of key extracellular matrix molecules in mesenchymal cells, and hyperactivation of IFN signaling in endothelial cells.

conclusionsThis single-cell dataset of T21 lungs greatly expands our understanding of antecedents to pulmonary complications and should facilitate efforts to mitigate respiratory disease in DS.

Indexed as

Down SyndromeLungTranscriptomeFemaleGene Expression ProfilingGene Expression Regulation, DevelopmentalHumansSingle-Cell AnalysisDown syndromelung developmenttranscriptomics

Identifiers

PMID40997082
PMCPMC13105331

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.